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__________________________________________________________________________22 
ABSTRACT 23 
 24 
The in vitro bioactivity of 5 kDa ultrafiltration permeate fractions of casein hydrolysates 25 
produced using different enzymes were compared. Reverse phase ultra-performance liquid 26 
chromatography and gel permeation chromatography showed that the permeates had different 27 
physicochemical properties (molecular mass and degree of hydrolysis). The Flavourzyme® 28 
permeate had the highest activity in the 2,2’-azinobis(3-ethylbenzothiazoline-6-sulphonic 29 
acid) (ABTS) assay. Cellular antioxidant and immunomodulatory assays showed that none of 30 
the permeates exhibited in vitro antioxidant activity, while all permeates significantly (P < 31 
0.05) decreased interleukin-6 (IL-6) production in ConA-stimulated Jurkat T cells at 0.50% 32 
(w/v) and LPS-stimulated RAW264.7 cells at 0.05 and 0.50% (w/v). Three permeates, 33 
obtained using Flavourzyme®, Flavorpro Whey and trypsin, also significantly (P < 0.05) 34 
decreased IL-1β production at 0.05% (w/v) in RAW264.7 cells. Western blot analysis 35 
showed that all permeates significantly decreased the expression of the NF-κB subunit, p65, 36 
in RAW264.7 cells indicating that anti-inflammatory activity may be associated with this 37 
pathway.  38 
___________________________________________________________________________ 39 
  40 
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1.  Introduction 41 
 42 
Cardiovascular disease (CVD), in particular atherosclerosis, is associated with 43 
elevated inflammation and oxidative stress. Drugs used to treat these conditions may produce 44 
unwanted side effects, therefore natural alternatives to synthetic drugs are constantly sought 45 
(Chakrabarti, Jahandideh & Wu, 2014). Bioactive peptides are small protein fragments that 46 
have the potential to exert beneficial health effects in vivo (Urista, Fernández, Rodriguez, 47 
Cuenca & Jurado, 2011). Bioactive peptides, derived from the milk protein casein, 48 
demonstrate numerous bioactivities such as antihypertensive, opioid and antimicrobial 49 
activity (Di Pierro, O’Keeffe, Poyarkov, Lomolino, & FitzGerald, 2014; Kazlauskaite et al., 50 
2005; Nongonierma, O’Keeffe, & FitzGerald, 2016; Phelan, Aherne-Bruce, O’Sullivan, 51 
FitzGerald, & O’Brien, 2009; Tang et al., 2015; Trivedi, Zhang, Lopez-Toledano, Clarke, & 52 
Deth, 2016; Yamada et al., 2015). The enzymes used in the generation of these peptides, as 53 
well as the length and amino acid sequence of the resultant peptides influence the 54 
bioactivities observed (Power, Jakeman, & FitzGerald, 2013).   55 
Casein hydrolysates with cellular antioxidant activity have been reported in numerous 56 
studies. Garcia-Nebot, Cilla, Alegría, and Barberá (2011) reported that 57 
caseinophosphopeptides showed cyto-protective effects against H2O2-induced oxidative 58 
stress in Caco-2 cells. Xie, Wang, Ao, and Li (2013) reported that an Alcalase® generated 59 
hydrolysate protected HepG2 cells from H2O2-induced oxidative damage. Hydrolysis of 60 
bovine casein glycomacropeptide with papain was also reported to protect against H2O2-61 
induced oxidation in RAW264.7 cells, along with increasing the level of cellular antioxidant 62 
enzymes (Cheng, Gao, Song, Ren, & Mao, 2015). Treatment of Jurkat T cells with casein 63 
hydrolysates generated using different mammalian, plant or bacterial enzymes has previously 64 
been reported to increase cellular antioxidant levels (Lahart et al., 2011; Phelan et al., 2009). 65 
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More recently, the hydrolysis of casein using Prolyve®, generated a hydrolysate which 66 
prevented H2O2-induced DNA damage in U937 cells (Cermeño, FitzGerald, & O’Brien, 67 
2016). 68 
Casein hydrolysates have also been studied for their immunomodulatory and anti-69 
inflammatory potential. The tryptic hydrolysis of casein generated a hydrolysate with 70 
immune enhancing effects in mouse macrophages (Kazlauskaite et al., 2005), while β-casein 71 
and several peptides within β-casein have been reported to decrease proliferation in murine 72 
spleen cells (Bonomi et al., 2011). Studies have also reported that the activity of NF-κβ, one 73 
of the major inflammatory signalling pathways, may be reduced in cells exposed to casein 74 
hydrolysates (Altmann et al., 2016; Malinowski, Klempt, Clawin-Rädecker, Lorenzen, & 75 
Meisel, 2014). The hydrolysis of casein using mammalian, bacterial or plant derived enzymes 76 
has also been reported to have immunomodulating effects on Jurkat T cells in other studies 77 
(Cermeño et al., 2016; Lahart et al., 2011; Phelan et al., 2009). To the best of our knowledge, 78 
no study has compared the cellular antioxidant and anti-inflammatory activities of sodium 79 
caseinate hydrolysates generated under the same conditions [hydrolysis time and 80 
enzyme:substrate (E:S) ratio], using a range of proteolytic preparations.  81 
The aims of the present study were: (i) to generate and examine the physicochemical 82 
characteristics of 5 kDa permeates of casein hydrolysates generated using seven different 83 
proteolytic preparations, (ii) to compare the antioxidant activity of the hydrolysates in vitro 84 
and in H2O2-challenged U937 cells; (iii) to determine cytotoxicity in RAW264.7 mouse 85 
macrophages, Jurkat T cells and U937 lymphocytes and (iv) to compare the 86 
immunomodulatory activity of the 5 kDa permeates of the hydrolysates in RAW264.7 87 
macrophages and Jurkat T cells.  88 
 89 
2.  Materials and methods 90 
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 91 
2.1. Materials 92 
 93 
Human Jurkat T cells, RAW264.7 mouse macrophages and human U937 lymphocytes 94 
were purchased from the European Collection of Animal Cell cultures (Salisbury, UK). 95 
Foetal bovine serum (FBS) was purchased from Invitrogen (Paisley, Scotland, UK). Cell 96 
culture plastics were supplied by Cruinn Diagnostics (Dublin, Ireland). Sodium caseinate 97 
(87.57% (w/w) protein) was from Arrabawn Co-op (Tipperary, Ireland). Protease from 98 
Bacillus licheniformis (Alcalase® 2.4L), protease from Aspergillus oryzae (Flavourzyme®, ≥ 99 
500 U g-1) and TPCK-trypsin were from Sigma-Aldrich (Wicklow, Ireland). Prolyve 1000 100 
was from Lyven Enzymes Industrielles (Caen, France) and Flavorpro Whey, Promod 144MG 101 
and Pepsin were all from Biocatalysts (Cefn Coed, Wales, UK). All other cell culture 102 
reagents and chemicals including concanavalin A (ConA), lipopolysaccharide (LPS) and 103 
Trolox were purchased from Sigma-Aldrich, unless otherwise stated. 104 
 105 
2.2. Generation of casein hydrolysates, determination of the degree of hydrolysis and 106 
ultrafiltration  107 
 108 
Sodium caseinate, reconstituted at 10% (w/v) in distilled water, was equilibrated at 50 109 
°C with gentle mixing for 1.5 h and the pH was adjusted to pH 7 (or pH 2 for peptic 110 
hydrolysis). Enzymatic hydrolysis was carried out using a pH Stat (718 Stat Titrino, 111 
Metrohm, Herisau, Switzerland) as previously described (Spellman, McEvoy, O’Cuinn, & 112 
FitzGerald, 2003). Hydrolysis was performed using seven different proteolytic preparations 113 
(Alcalase® 2.4L, Prolyve 1000, Flavourzyme®, Flavorpro Whey, Pepsin, TPCK-Trypsin and 114 
Promod 144 MG) at industrially relevant E:S ratios (0.23% for Alcalase® 2.4L, Prolyve 1000 115 
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and Flavourzyme®, Flavorpro Whey and Promod 144 MG, 0.13% for trypsin and 0.25% for 116 
pepsin) for 4 h, except for the tryptic hydrolysate that was generated over 3 h.  117 
Following hydrolysis, the enzymes were inactivated by heating at 80 °C for 20 min. 118 
Control samples were also included; (i) sodium caseinate was incubated at 50 °C without 119 
enzyme and (ii) enzyme was incubated at 50 °C without sodium caseinate. These control 120 
samples were also subjected to heating at 80 °C for 20 min after 4 h incubation. All samples 121 
were freeze-dried (FreeZone 18L, Labconco, Kansas City, USA) and stored at –20 °C until 122 
use. The degree of hydrolysis (DH) of the hydrolysates was determined using the 2,4,6-123 
trinitrobenzenesulfonic acid (TNBS) method of Adler-Nissen (1979) and as described by Le 124 
Maux, Nongonierma, Barre, and FitzGerald (2016). Ultrafiltration (UF) fractions were 125 
generated by passing the hydrolysate through a membrane having a nominal cut-off of 5 kDa 126 
using a benchtop ultrafiltration system (Sartoflow Alpha, Sartorius AG, Goettingen, 127 
Germany) as described by O'Keeffe and FitzGerald (2014) and were freeze-dried as above. 128 
 129 
2.3. Reverse phase ultra-performance liquid chromatography and gel permeation high 130 
performance liquid chromatography analysis of UF permeates of casein hydrolysates 131 
 132 
Freeze-dried hydrolysates/ultrafiltration permeates were reconstituted at 1 mg mL-1 in 133 
mobile phase A [0.1% trifluoroacetic acid (TFA) in MS grade H2O] and 7 µL was separated 134 
on an ACQUITY ultra-performance liquid chromatography (UPLC) system (Waters, Milford, 135 
Massachusetts, USA) at a flow rate of 0.2 µL min-1 using an ACQUITY BEH 300 C18 136 
column (2.1 × 50 mm, 1.7 µm; Waters, Dublin, Ireland). Mobile phase B was 0.1% TFA in 137 
80% ACN. Separation was achieved using a linear gradient; 0–0.28 min 100% A; 0.28–45 138 
min 100–20% A; 45–46 min 20–0% A; 46–48 min 0% A; 48–49 min 0–100% A; 49–51 min 139 
100% A. Detector response was measured at 214 nm. Gel permeation high performance 140 
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liquid chromatography (GP-HPLC) was performed as previously described (Spellman, 141 
O’Cuinn, & FitzGerald, 2009) with separation achieved through isocratic elution (mobile 142 
phase: 0.1%TFA in 30% ACN at 1.0 mL min-1) on a TSK G2000 SW column (600 × 7.5 mm 143 
ID) connected to a TSKGEL SW guard column (75 × 7.5 mm ID) and the eluent was 144 
monitored at 214 nm.  145 
 146 
2.4. 2,2’-azinobis(3-ethylbenzothiazoline-6-sulphonic acid) assay 147 
 148 
The 2,2’-azinobis(3-ethylbenzothiazoline-6-sulphonic acid)+ (ABTS+) radical 149 
scavenging assay was carried out as described by Re et al. (1999). The ABTS+ radical was 150 
prepared by incubating ABTS solution (7 mM) with potassium persulfate (2.45 mM), an 151 
oxidizing agent, in a ratio of 1.0:0.5 (v/v) at 20 °C for 16 h in the dark. The radical was then 152 
diluted using phosphate buffered saline (5 mM, pH 7.4) until an absorbance of 0.70 ± 0.02 at 153 
a wavelength of 734 nm was achieved. Activity was reported based on a standard curve using 154 
Trolox and expressed as µmol Trolox equivalents per gram of freeze-dried powder of 155 
hydrolysate (FDP). The scavenging activity for each sample was determined by three 156 
independent experiments.  157 
 158 
2.5. Oxygen radical absorbance capacity assay 159 
 160 
The oxygen radical absorbance capacity (ORAC) assay was performed according to 161 
the method of Zulueta, Esteve, and Frígola (2009) with modifications as described by 162 
O’Keeffe and FitzGerald (2014). The final ORAC values were expressed as µmol of Trolox 163 
equivalents per mg of FDP and were the mean ± the standard error of three independent 164 
determinations. 165 
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 166 
2.6. Cell culture 167 
 168 
Jurkat T and U937 cells were maintained in Royal Park Memorial Institute (RPMI) 169 
medium supplemented with 10% (v/v) foetal bovine serum (FBS). RAW264.7 cells were 170 
grown in Dulbecco’s Modified Eagle’s Medium (DMEM) supplemented with 10% (v/v) 171 
FBS. All cell lines were cultured in an atmosphere of CO2-air (5:95, v/v) at 37 °C and were 172 
maintained in the absence of antibiotics. The dried 5 kDa permeates of the casein 173 
hydrolysates were solubilised to a concentration of 10% (w/v) using distilled deionised water, 174 
sterile-filtered using a low protein binding 0.22 µm DuraporeTM millex filter unit (Merck 175 
KGaA) and diluted with sterile DMEM. 176 
 177 
2.7. Cell proliferation assay 178 
 179 
Jurkat T, U937 and RAW264.7 cells were exposed to increasing concentrations of the 180 
different 5 kDa permeates (0.05 to 5.0%, w/v) for 24 h in 96 well plates in a final volume of 181 
200 µL. Cell proliferation was measured using the 3-(4, 5-dimethylthiazol-2-yl)-2, 5-182 
diphenyltetrazolium bromide (MTT) assay (MTT I proliferation kit, Roche Diagnostics; 183 
Burgess Hill, West Sussex, UK).  184 
 185 
2.8. Alkaline single cell gel electrophoresis (comet) assay 186 
 187 
U937 cells were used to assess the DNA protective effects of the 5 kDa permeates in 188 
oxidant challenged cells. Cells were seeded at a density of 1 × 105 cells mL-1 and exposed to 189 
the permeates (0.05%, w/v) for 24 h. DNA damage was then initiated by exposing cells to 80 190 
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µmol L-1 H2O2 for 30 min at 37 °C after which DNA damage was assessed using the comet 191 
assay as previously described (Phelan et al., 2009).   192 
 193 
2.9. Cytokine production in Jurkat T and RAW264.7 cells 194 
 195 
Jurkat T cells were seeded at a density of 2 × 105 cells mL-1 and simultaneously 196 
incubated with ConA (25µg mL-1) and the 5 kDa permeates (0.50 and 0.05%, w/v) for 24 h.  197 
Following incubation, the quantity of interleukin (IL)-6), interferon (IFN)-γ, IL-2 and IL-10 198 
in the media was measured by enzyme-linked immunosorbent assay (ELISA) (eBioscience, 199 
Insight Biotechnology Ltd, Wembley, UK).  RAW264.7 cells were seeded at a density of 0.2 200 
× 105 cells mL-1 and simultaneously incubated with LPS (0.1 µg mL-1 for IL-6 and tumour 201 
necrosis factor (TNF)-α; 2 µg mL-1 for IL-1β) and the 5 kDa permeates (0.050% and 0.005, 202 
w/v) for 24 h.  Following incubation, the content of each of the three cytokines (IL-6, Il-1β 203 
and TNF-α) in the media was measured using ELISA kits. Absorbance was determined at 204 
450 nm with a reference wavelength of 570 nm (Varioskan™ Flash Multimode Reader, 205 
Thermoscientific, Waltham, MA, USA). 206 
 207 
2.10. Western blotting 208 
 209 
RAW264.7 cells were seeded at a density of 8 × 105 cells per dish in 60 mm dishes 210 
and allowed to adhere overnight. Cells were then stimulated using LPS (0.1 µg mL-1) and 211 
treated with the permeates (0.05%, w/v) for 24 h. After this treatment, the RAW264.7 cells 212 
were washed using ice cold PBS and lysed using RIPA buffer containing protease (Halt 213 
protease inhibitor, Sigma 78439) and phosphatase inhibitors (1 mM NaVO4, 2.5 mM Na4O7P2 214 
and 2 mM β-glycerophosphate). Cell lysates were then scraped and transferred to Eppendorf 215 
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tubes and placed on ice for 20 min. Lysates were centrifuged at 25,155 × g for 1 h at 4 °C and 216 
the supernatant transferred to fresh Eppendorf tubes. Protein concentration was determined 217 
using the BCA method (Smith et al., 1985) and samples were stored at –80 °C until Western 218 
blot analysis.  219 
Proteins were separated using a 10% sodium dodecyl sulphate polyacrylamide 220 
electrophoresis (SDS-PAGE) gel and transferred to a polyvinylidene fluoride membrane. The 221 
membrane was then blocked overnight at 4 °C using Odyssey Blocking buffer with 0.1% 222 
Tween-20. The following day, the membrane was washed using Tris-buffered saline-Tween-223 
20 (TBS-T) and incubated with mouse anti-p65 antibody overnight at 4 °C. Following 224 
incubation, the membrane was again washed using TBS-T and incubated for a further hour at 225 
room temperature with Infrared-labelled goat anti-mouse secondary antibody (LI-COR Inc.). 226 
Finally, the membrane was washed using TBS-T, followed by TBS to remove any remaining 227 
Tween-20. The Odyssey Clx Imager was used to visualise protein bands. Protein loading was 228 
determined using β-actin as a control. 229 
 230 
2.11. Statistical analysis 231 
 232 
Statistical analysis was determined by ANOVA followed by Dunnett’s test or Tukey’s 233 
post-hoc test using Prism 5.0 (GraphPad Inc. San Diego, California, USA). Results are 234 
expressed as mean ± SE or mean ± SD. Statistical significance was P < 0.05.  235 
 236 
3.  Results 237 
 238 
3.1. Physicochemical characterisation, degree of hydrolysis and in vitro antioxidant 239 
assessment of casein hydrolysates 240 
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 241 
The different proteolytic preparations produced hydrolysates having distinctly 242 
different RP-UPLC (Fig. 1) and GPC (Fig. 2) profiles demonstrating the differing 243 
specificities of the proteolytic preparations. The higher specificity of TPCK-Trypsin and 244 
pepsin resulted in a lower proportion of low molecular mass (< 500 Da) peptides present in 245 
these samples (Fig. 2) and in a lower DH (Table 1). Alcalase®, Flavourzyme® and Prolyve 246 
hydrolysis resulted in hydrolysates with the highest proportion of low molecular mass 247 
peptides (< 500 Da) and the highest degree of hydrolysis (~14–18%).  248 
All 5 kDa permeates showed significantly (P < 0.05) higher antioxidant activity than 249 
intact sodium caseinate or the full hydrolysates in both the ORAC and ABTS+ assays (data 250 
not shown). There was no significant (P < 0.05) difference in antioxidant activity between the 251 
different 5 kDa permeates when measured by the ORAC assay, while the 5 kDa UF permeate 252 
of the Flavourzyme® hydrolysate had the highest activity in the ABTS assay (Table 1); 253 
significantly (P < 0.05) higher than that of the 5 kDa UF permeate of the tryptic hydrolysate. 254 
There was no correlation between the DH of the hydrolysates and the antioxidant activity (via 255 
ORAC or ABTS+ assays) of the corresponding 5 kDa UF fractions (Table 1). 256 
 257 
3.2. Effects of casein hydrolysate 5 kDa permeates on cell proliferation in RAW264.7 258 
mouse macrophages, human U937 lymphocytes and human Jurkat T cells. 259 
 260 
RAW264.7 mouse macrophages were exposed to increasing concentrations (0–5% 261 
w/v) of the different 5 kDa permeates for 24 h. The MTT assay was then used to assess the 262 
effect of each hydrolysate on cell proliferation.  Proliferation was generally unaffected by the 263 
permeates up to a concentration of 1% (w/v) (Table 2). At a concentration of 5% (w/v), cell 264 
proliferation declined significantly (P < 0.05) in cells incubated with hydrolysate permeates 265 
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generated using Flavorpro Whey, trypsin and pepsin. For Jurkat T cells, the 5 kDa permeates 266 
obtained from hydrolysates generated using Promod, trypsin and pepsin significantly (P < 267 
0.05) decreased cell proliferation at 5% (w/v), while the Flavourzyme® hydrolysate permeate 268 
significantly (P < 0.05) increased cell proliferation at this concentration (Table 3). A similar 269 
trend was seen with 5 kDa permeates in U937 cells (Table 4). Concentrations of 0.050 and 270 
0.005% (w/v) were, therefore, selected for bioactivity assays involving RAW264.7 cells. 271 
Non-cytotoxic concentration of 0.50 and 0.05% (w/v) for Jurkat T cells, and 0.05% (w/v) for 272 
U937 were used for bioactivity assays ensuring that all cell viabilities remained greater that 273 
85%.  274 
 275 
3.3. Antioxidant activity of casein hydrolysate 5 kDa permeates 276 
 277 
The comet assay was used to assess the DNA protective effect of the 5 kDa permeates 278 
against H2O2-induced DNA damage in U937 cells. Tail DNA was increased to approximately 279 
80% in U937 cells exposed to H2O2 (80 µmol L-1) for 30 min from a control level of 280 
approximately 16% in untreated cells. Pre-incubation of U937 cells with the different 281 
permeates at 0.05% (w/v) for 24 h did not protect cells against H2O2–induced DNA damage 282 
(Fig. 3). 283 
 284 
3.4. Cytokine production in Jurkat T cells 285 
 286 
Jurkat T cells were stimulated to produce cytokines using 25 µg mL-1 ConA, 287 
following which cytokine (IL-6, IFN-γ, IL-2 and IL-10) production was measured.  IL-6 288 
production was seen to decrease in cells exposed to the 5 kDa permeates (Table 5). All 289 
hydrolysate permeates at 0.50% (w/v) produced a significant (P < 0.05) decrease in IL-6 290 
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production compared with control values. No significant (P < 0.05) effects were seen in IL-2, 291 
IL-10 and IFN-γ production after exposure to the 5 kDa permeates at either 0.50 or 0.05% 292 
(w/v). 293 
 294 
3.5. Cytokine production in RAW264.7 cells 295 
 296 
RAW264.7 cells were stimulated with LPS at 0.1 µg mL-1 or 2 µg mL-1 and treated 297 
with 5 kDa permeates for 24 h before cytokine analysis (Table 6). At 0.05% (w/v), each of 298 
the hydrolysate fractions caused a significant (P < 0.05) decrease in IL-6 production 299 
compared with cells incubated with LPS alone. At 0.005% (w/v), none of the hydrolysate 300 
fractions caused significant (P < 0.05) decreases in IL-6 production. Hydrolysate permeates 301 
generated using Flavourzyme®, Flavorpro Whey and trypsin caused a significant (P < 0.05) 302 
decrease in IL-1β production in cells incubated with these samples at 0.050% (w/v).  No 303 
effect was seen in TNF-α production after treatment with the 5 kDa permeates at any 304 
concentration. 305 
 306 
3.6. NF-κB protein expression in RAW264.7 cells 307 
 308 
RAW264.7 cells were stimulated using 0.1 µg mL-1 LPS and treated with the 5 kDa 309 
permeates at 0.050% (w/v) for 24 h in 60 mm dishes. Cells were then lysed and cell lysates 310 
were examined for protein expression of the NF-κB subunit, p65. All hydrolysate fractions 311 
caused a significant (P < 0.05) decrease in p65 protein expression compared with cells treated 312 
with LPS alone (Fig. 4). 313 
 314 
4.  Discussion 315 
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 316 
It is recognised that utilisation of a variety of analytical techniques is required to 317 
capture differing pathways of antioxidant activity. The ORAC assay measures the ability of 318 
an antioxidant to prevent peroxyl radical oxidation of a fluorescent probe by means of 319 
hydrogen atom transfer (HAT). In the ABTS assay, the antioxidant present in the permeate 320 
sample scavenges the ABTS radical cation (ABTS•+) by means of electron transfer (Power et 321 
al., 2013). In the present study, during initial experimentation it was observed that 322 
concentration of the low molecular mass peptides on processing through a UF membrane 323 
having a molecular mass cut-off of 5 kDa resulted in an increase in the antioxidant activity as 324 
measured by the ORAC assay. However, no further increase in antioxidant activity was 325 
achieved on further processing through a 1 kDa membrane (data not shown). Therefore, the 5 326 
kDa permeates of each of the hydrolysates were used for all other determinations.  327 
Studies have reported that casein hydrolysates possess non-cellular antioxidant 328 
activity, mainly radical scavenging or electron donating ability. Alcalase® has been 329 
frequently used to produce such hydrolysates (Ao & Li, 2013; Chen & Li, 2012; De Gobba, 330 
Tompa, & Otte, 2014; Xie, Liu, Wang, & Li, 2014; Xie, Wang, Jiang, Liu, & Li, 2015). 331 
Alcalase® was also used in this study; however, no significant difference was seen in the 332 
antioxidant activity of this hydrolysate compared with hydrolysates produced by the other 333 
enzyme preparations and, interestingly, Flavourzyme® produced a hydrolysate with higher 334 
ABTS activity. This may be due to the presence of a larger number of peptides below 500 Da 335 
in the Flavourzyme hydrolysate.  336 
No cellular antioxidant activity was observed with the hydrolysates in the present 337 
study. Previously, Phelan et al. (2009) reported that non-ultrafiltered casein hydrolysates 338 
generated using commercial food-grade enzyme preparations altered glutathione and catalase 339 
(CAT) activity in Jurkat T cells, but did not prevent H2O2-induced DNA damage in Caco-2 340 
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cells. Cermeño et al. (2016) reported that a casein hydrolysate, generated using Prolyve, 341 
significantly (P < 0.05) protected U937 cells from H2O2-induced DNA damage. The 5 kDa 342 
permeate of the Prolyve hydrolysate herein was generated using similar conditions; however, 343 
no cell protective effect was seen. Notably, the full hydrolysate was used in Cermeño et al. 344 
(2016) while our study used the 5 kDa permeate fraction; this may imply that the cell 345 
protective effect was associated with higher molecular mass peptides. Xie et al. (2013) found 346 
that casein hydrolysates produced using Alcalase® or the simulated gastrointestinal digestion 347 
of casein showed significant protective effects in challenged HepG2 cells by reducing oxidant 348 
induced cell death. A follow-on study reported that the Alcalase® hydrolysis of casein 349 
produced hydrolysate fractions which enhanced catalase and superoxide dismutase activity 350 
and increased viability in H2O2-exposed HepG2 cells. The hydrolysate was fractionated based 351 
on charge and negatively charged fractions had greater antioxidant activity (Wang, Xie, & Li, 352 
2016). Results herein indicate that the enzymes used did not affect antioxidant activity as 353 
hydrolysate 5 kDa permeates with similar activity were produced in all cases.  354 
In the present study, hydrolysates significantly decreased pro-inflammatory cytokine 355 
production (IL-6 and IL-1β) in T cells and macrophages. Casein hydrolysates, produced using 356 
combinations of TGase and Prolyve were previously reported to significantly decrease IL-6 357 
production in Jurkat T cells (Cermeño et al., 2016). Malinowski et al. (2014) also reported 358 
that a tryptic hydrolysate of bovine β-casein had significant anti-inflammatory activity in 359 
kidney cells. In this case, casein was hydrolysed for 4 h and the hydrolysate 1–5 kDa 360 
permeate fractions exhibited significant anti-inflammatory activity in human kidney cells. It 361 
was suggested that a group of large hydrophobic peptides were responsible for the anti-362 
inflammatory activity. The hydrolysis of β-casein using cod trypsin has also been reported to 363 
have anti-inflammatory activity in kidney cells and larger peptides (> 5 kDa) were reported to 364 
have higher activity compared with lower molecular mass peptides (Altmann et al., 2016).  365 
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The hydrolysis of sodium caseinate using a bacterial enzyme has also been reported to 366 
reduce IL-8 production in TNF-α stimulated Caco-2 cells, as well as downregulating several 367 
pro-inflammatory cytokines expression in LPS-stimulated colonic tissue. Activity was 368 
reported to be highest in the 1 kDa retentate fraction in this case (Mukhopadhya et al., 2014). 369 
All the hydrolysates in the present study were 5 kDa permeates and had significant anti-370 
inflammatory activity, particularly those produced using trypsin, Flavourzyme® and 371 
Flavorpro Whey.  372 
Two enzyme-only controls were generated based on the high activity of the 373 
corresponding hydrolysates and these controls were screened for anti-inflammatory activity 374 
in RAW264.7 cells to rule out reagent/enzyme related activity. Enzyme-only controls had 375 
little anti-inflammatory activity (data not shown), therefore it was determined that the 376 
observed anti-inflammatory activity was due to the hydrolysis of casein by these enzymes. 377 
Flavourzyme® has previously been shown to generate hydrolysates from brewer’s spent 378 
grain that were capable of decreasing IFN-γ production in Jurkat T cells (McCarthy et al., 379 
2013a,b). Bamdad, Shin, Suh, Nimalaratne, and Sunwoo (2017) also reported that a 380 
Flavourzyme® generated casein hydrolysate decreased nitric oxide production and TNF-α 381 
mRNA expression in RAW264.7 cells; however, this hydrolysate was produced using a 382 
combined treatment of high hydrostatic pressure and enzymatic digestion. To the best of our 383 
knowledge, no other studies have previously reported anti-inflammatory activity with 384 
Flavorpro Whey generated casein hydrolysates.  385 
In the present study, while hydrolysate treatment resulted in a decrease in IL-6 and 386 
IL-1β production, TNF-α production was unaffected. Yak milk casein hydrolysates, produced 387 
using Alcalase®, were reported to decrease the production of IL-6, IL-1β and TNF-α in 388 
macrophages (Mao, Cheng, Wang, & Wu, 2011). Hydrolysates used in the study by Mao et 389 
al. (2011) had significant in vitro antioxidant activity that may have contributed to the 390 
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enhanced anti-inflammatory response; IL-6 and IL-1β production in macrophages was 391 
decreased by ~70% and 60%, respectively, in the study by Mao et al. (2011) compared with 392 
~55% and 30%, respectively, in our study. The differing amino acid compositions of milk 393 
from different species may also have affected activity, as reported by a study which reported 394 
higher antioxidant activity in camel milk casein hydrolysates compared with bovine milk 395 
casein hydrolysates (Moslehishad et al., 2013).  396 
The NF-κB pathway is a major transcription pathway in cells linked to inflammation 397 
and chronic inflammatory diseases such as atherosclerosis, inflammatory bowel disease and 398 
cancer (Yamamoto & Gaynor, 2001). In the current study, the NF-κB subunit p65 (also 399 
known as RELA), which is involved in nuclear translocation and activation, was studied after 400 
treatment with hydrolysate fractions in LPS-stimulated RAW264.7 cells. The anti-401 
inflammatory activity of all seven hydrolysate 5 kDa permeates may be linked to NF-κB 402 
activation as the protein expression of p65 was inhibited in all cases. Milk-derived 403 
hydrolysates with anti-inflammatory activity have previously been reported to act through the 404 
NF-κB pathway in different cell lines (Altmann et al., 2016; Malinowski et al., 2014; 405 
Marcone, Haughton, Simpson, Belton, & FitzGerald, 2015; Nielsen, Theil, Larson, & Parup, 406 
2012). To the best of our knowledge, our study is the first to examine the molecular 407 
mechanism behind the anti-inflammatory activity of bovine casein hydrolysates in 408 
macrophages. A study of rice protein hydrolysates, prepared using trypsin, yielded similar 409 
results to our study, where IL-6 and IL-1β expression in LPS-stimulated RAW264.7 cells 410 
were decreased after 24 h hydrolysate treatment and p65 translocation to the nucleus was also 411 
decreased (Wen et al., 2016).  412 
 413 
5.  Conclusions  414 
 415 
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The 5 kDa UF permeates of casein hydrolysates produced using mammalian, plant, 416 
fungal and bacterially-derived proteolytic preparations showed significant in vitro anti-417 
inflammatory activity in Jurkat T cells and RAW264.7 macrophages. These hydrolysate 418 
permeates had a greater anti-inflammatory effect on IL-6 production in RAW264.7 cells 419 
compared with Jurkat T cells. Three of the hydrolysate permeates also significantly decreased 420 
IL-1β production in RAW264.7 cells and were produced using either fungal or mammalian 421 
derived enzymes. Based on the ability of the hydrolysate 5 kDa permeates to significantly 422 
inhibit the expression of the NF-κB subunit, p65, our results also indicate that this anti-423 
inflammatory activity may be dependent on the NF-κB inflammatory pathway. Future studies 424 
on the in vivo anti-inflammatory activity of hydrolysate permeates, generated using fungal or 425 
mammalian derived enzymes, may be of interest. 426 
 427 
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Figure legends 1 
 2 
Fig. 1. Reversed phase ultra-performance liquid chromatography profiles of (a) sodium caseinate and 3 
(b–h) casein hydrolysate 5 kDa permeates where the enzymatic preparations employed were: (b) 4 
Alcalase® 2.4L; (c) Flavourzyme®; (d) Prolyve 1000; (e) Flavorpro Whey; (f) Promod 144MG; (g) 5 
Trypsin; (h) Pepsin. 6 
 7 
Fig. 2. Molecular mass distribution profiles of intact sodium caseinate and 5 kDa ultrafiltration 8 
permeates of sodium caseinate hydrolysates generated with different enzymatic preparations using gel 9 
permeation chromatography; , < 500 Da; , 1000–500 Da;     , 2000–1000 Da;     , 5000–2000 Da; 10 
    , 10,000–5,000 Da;     , > 10,000 Da. 11 
 12 
Fig. 3. The ability of 5 kDa ultrafiltration permeates of sodium caseinate hydrolysates (0.05%, w/v) to 13 
protect against H2O2 induced DNA damage in U937 lymphocytes; H, cells treated with H2O2 only. 14 
Tail DNA damage was measured using the comet assay and expressed as a percentage relative to 15 
hydrogen peroxide control values (untreated cells). Data are means ± SD of 2 independent 16 
experiments; significance was measured using ANOVA followed by Dunnett’s test. 17 
 18 
Fig. 4. Effect of 5 kDa ultrafiltration permeates of sodium caseinate hydrolysates (0.05%, w/v) on 19 
NF-κB (p65) protein expression in RAW264.7 cells relative to cells treated with LPS alone (Control, 20 
assigned at 100%); p65 protein expression was assessed in LPS stimulated RAW264.7 cells by 21 
Western Blot after 24 h sample treatment. The data show one of three independent experiments, 22 
which yielded similar results and are the means ± SE of 3 independent experiments; significance was 23 
measured using ANOVA followed by Dunnett’s test; * denotes P < 0.05. 24 
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Table 1 
Oxygen radical absorbance capacity (ORAC) and 2,2'-azino-bis(3-ethylbenzothiazoline-6-sulphonic 
acid) (ABTS) radical scavenging activities of 5 kDa ultrafiltration permeates of sodium caseinate 
hydrolysates generated with different enzymatic preparations. a 
Enzyme  Degree of hydrolysis  
(%) 
ORAC value 
(µmol TE mg-1 FDP) 
ABTS value 
(µmol TE g-1 FDP) 
Alcalase® 18.01 ± 1.59a 1.072 ± 0.07a 52.86 ± 3.46a,b 
Flavourzyme® 14.43 ± 0.61b 1.130 ± 0.076a 71.18 ± 7.65a 
Prolyve 15.65 ± 0.60a,b 1.120 ± 0.088a 58.38 ± 3.48a,b 
Flavorpro Whey 12.86 ± 0.89b 1.154 ± 0.007a 67.59 ± 4.91a,b 
Promod 144MG 5.23 ± 0.42c,d 1.080 ± 0.085a 52.14 ± 2.19a,b 
Trypsin 7.21 ± 0.72c 1.080 ± 0.041a 44.23 ± 4.83b,c 
Pepsin 2.31 ± 0.61d 1.120 ± 0.044a 59.00 ± 4.50a,b 
 
a
 Abbreviations are: TE, Trolox equivalents; FDP, freeze dried powder of hydrolysate The degree of 
hydrolysis was calculated for the full hydrolysates prior to ultrafiltration. Data are the mean ± SEM of 
3 independent experiments; values with different superscript letters are significantly different at P < 
0.05 within each assay.  
  
M
AN
US
CR
IP
T
 
AC
CE
PT
ED
ACCEPTED MANUSCRIPT
Table 2 
Effect of 5 kDa ultrafiltration permeates of sodium caseinate hydrolysates (0–5%, w/v) generated using 
different enzyme preparations on proliferation in RAW264.7 mouse macrophages. a 
Enzyme  Cell proliferation (% control) with 5 kDa ultrafiltration permeates (%, w/v) 
      0.05 0.10 0.50 1.00 5.00 
Alcalase® 109.8± 6.7 116.8±6.5 122.2±7.2 120.0±7.6 87.0±10.5 
Flavourzyme® 106.8±5.8 106.7±4.3 111.8±5.7 110.6±4.6 74.0±16.8 
Prolyve 107.7±5.5 107.7±7.0 109.5±5.6 109.3±6.1 77.8±13.2 
Flavorpro Whey 106.7±9.8 106.6±5.7 103.6±1.2 97.9±1.6 40.4±9.6* 
Promod 144MG 99.5±3.1 99.2±4.0 92.0±9.5 90.3±9.3 68.9±13.5 
Trypsin 68.7±9.5 64.0±15.7 91.2±5.8 89.9±7.7 59.2±8.7* 
Pepsin 107.1±3.5 107.1±6.7 112.3±5.0 110.8±8.2 33.6±6.9* 
 
a RAW264.7 mouse macrophages were seeded at a density of 0.2 × 105 cells mL-1 and treated with 
increasing concentrations (0–5%, w/v) of samples for 24 h.  Cell proliferation was determined using 
the MTT assay and values are expressed as a percentage relative to untreated cells. Data are the mean 
± SE of 3 independent experiments; an asterisk denotes statistically significant difference (ANOVA 
followed by Dunnett’s test; P < 0.05) in cell proliferation, compared with untreated RAW264.7 cells.  
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Table 3 
Effect of 5 kDa ultrafiltration permeates of sodium caseinate hydrolysates (0–5%, w/v) on 
proliferation in human Jurkat T cells. a 
Enzyme  Cell proliferation (% control) with 5 kDa ultrafiltration permeates (%, w/v) 
0.05 0.10 0.50 1.00 5.00 
Alcalase® 89.3±7.5 84.0±10.4 77.9±9.1* 77.2±8.2* 84.3±4.3 
Flavourzyme® 91.1±7.5 96.1±1.2 96.1±4.0 117.6±9.1* 242.8±12.4* 
Prolyve 96.3±3.8 94.1±4.1 90.9±6.4 94.7±5.1 98.6±5.1 
Flavorpro Whey 95.1±2.8 92.7±1.8 90.0±1.6* 101.2±4.8 102.0±7.7 
Promod 144MG 98.3±5.9 94.5±5.8 81.6±1.3* 78.8±2.4* 83.8±4.4* 
Trypsin 96.9±1.7 90.7±2.6 76.2±9.9* 79.0±3.6* 78.4±5.2* 
Pepsin 95.8±7.3 94.6±3.4 78.9±2.8* 77.8±2.4* 13.4±0.5* 
 
a Jurkat T cells were seeded at a density of 1 × 105 cells mL-1 and treated with increasing 
concentrations (0–5%, w/v) of samples for 24 h. Cell proliferation was determined using the MTT 
assay and values are expressed as a percentage relative to untreated cells. Data are the mean ± SE of 3 
independent experiments; an asterisk denotes statistically significant difference (ANOVA followed by 
Dunnett’s test; P < 0.05) in cell proliferation, compared with untreated human Jurkat T cells.  
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Table 4 
Effect of 5 kDa ultrafiltration permeates of sodium caseinate hydrolysates (0–5%, w/v) on 
proliferation in human U937 lymphocytes. a 
Enzyme Cell proliferation (% control) with 5 kDa ultrafiltration permeates (%, w/v) 
0.05 0.10 0.50 1.00 5.00 
Alcalase® 102.7±3.3 96.3±4.3 84.9±4.3 84.4±4.4 76.3±9.8* 
Flavourzyme® 107.0±7.0 101.2±2.0 94.6±3.6 103.8±10.4 159.4±5.3* 
Prolyve 102.8±3.6 97.5±3.5 87.5±2.3 92.4±4.8 91.4±10.4 
Flavorpro Whey 95.3±3.1 97.6±1.3 94.3±1.6 94.1±6.8 56.8±6.8* 
Promod 144MG 101.5±6.6 89.1±8.3 87.6±1.2 82.5±5.4 71.4±6.3* 
Trypsin 99.4±5.0 94.2±2.7 85.8±2.5 80.6 ±5.2 62.8±9.8* 
Pepsin 93.7±4.4 94.6±1.9 83.1±3.9* 81.2±3.2* 12.2±0.9* 
 
a U937 lymphocytes were seeded at a density of 1 × 105 cells mL-1 and treated with increasing 
concentrations (0–5%, w/v) of samples for 24 h. Cell proliferation was determined using the MTT 
assay and values are expressed as a percentage relative to untreated cells. Data are the mean ± SE of 3 
independent experiments; an asterisk denotes statistically significant difference (ANOVA followed by 
Dunnett’s test; P < 0.05) in cell proliferation, compared with untreated human U937 cells.  
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Table 5 
Effect of 5 kDa ultrafiltration permeates of sodium caseinate hydrolysates (0.50 and 0.05%, w/v) on IL-6, IFN-γ, IL-2 and IL-10 production in Jurkat T 
lymphocytes. a 
 
Sample Cytokine production (% control)  
IL-6  IFN-γ  IL-2  IL-10 
0.50%  0.05% 0.50% 0.05% 0.50% 0.05% 0.50% 0.05% 
Control 100.0±0.0 100.0±0.0  100.0±0.0 100.0±0.0  100.0±.0.0 100.0±0.0  100.0±0.0 100.0±0.0 
Alcalase® 76.7±2.8* 87.8±2.9  91.0±3.9 97.5±2.8  103.4±3.8 103.4±3.8  105.9±4.0 103.8±2.9 
Flavourzyme® 81.7±2.1* 87.9±2.1  89.1±3.9 94.2±2.4  101.7±4.7 101.7±4.7  111.2±3.3 104.2±5.0 
Prolyve 79.5±1.0* 92.8±4.1  94.2±3.2 100.3±1.5  95.0±5.9 95.0±5.9  102.7±5.1 105.2±0.4 
Flavorpro Whey 83.6±0.8* 92.0±2.0  103.6±3.6 100.7±5.2  103.3±5.9 103.3±5.9  106.9±3.8 107.2±4.8 
Promod 144MG 79.4±1.5* 99.9±3.2  93.5±2.6 103.8±3.6  100.9±3.3 100.9±3.3  111.2±7.6 108.1±6.3 
Trypsin 80.9±1.5* 102.7±4.1  88.8±2.7 105.7±3.5  116.7±8.4 116.7±8.4  116.0±6.1 104.3±9.3 
Pepsin 87.2±2.1* 102.2±2.6  97.2±1.4 110.0±7.6  98.2±3.2 98.2±3.2  102.1±5.0 99.6±1.2 
 
a Jurkat T cells were seeded at a density of 2 × 105 cells mL-1, stimulated with ConA (25 µg mL-1) and treated with 0.50 and 0.05% (w/v) 5 kDa UF permeates 
of sodium caseinate hydrolysates for 24 h. Cytokine production was measured using the enzyme-linked immunosorbent assay (ELISA) and values were 
expressed as a percentage relative to cells treated with ConA alone (control): IL-6 concentration, control = 0.004 ng mL-1; IFN-γ concentration, control = 
0.099 ng mL-1; IL-2 concentration, control = 0.147 ng mL-1; IL-10 concentration, control = 0.156 ng mL-1. Data are the mean ± SE of 3 independent 
experiments; an asterisk denotes statistically significant difference (ANOVA followed by Dunnett’s test; P < 0.05) in cytokine production, compared with 
Jurkat T cells treated with ConA alone.  
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Table 6 
Effect of 5 kDa ultrafiltration permeates of sodium caseinate hydrolysates (0.050 and 0.005%, w/v) on IL-6, IL-1β and TNF-α production in RAW264.7 
mouse macrophages. a 
 
Sample Cytokine production (% control)  
IL-6  IL-1β  TNF-α  
0.050%  0.005% 0.050% 0.005% 0.050% 0.005% 
Control 100.0±0.0 100.0±0.0  100.0±0.0 100.0±0.0  100.0±0.0 100.0±0.0  
Alcalase® 55.4±7.4* 100.7±21.1  78.8±5.3 118.4±7.8  109.8±5.1 114.5±5.2  
Flavourzyme® 55.0±12.4* 82.1±7.1  74.7±8.2* 121.4±9.3  109.6±4.7 110.4±3.9  
Prolyve 54.2±3.8* 87.2±13.3  77.6±4.1 107.4±13.9  104.3±4.8 110.6±3.3  
Flavorpro Whey 47.2±8.9* 79.5±4.6  76.4±3.7* 113.2±14.5  107.5±5.1 112.4±4.7  
Promod 144MG 58.4±12.0* 87.9±8.1  96.1±2.9 115.0±13.0  108.1±5.6 109.4±4.0  
Trypsin 60.3±9.8* 99.8±19.7  74.8±2.1* 105.1±16.7  112.4±6.0 114.0±4.9  
Pepsin 55.7±4.0* 79.0±9.7  86.2±7.2 111.0±15.6  102.0±10.8 104.7±3.4  
 
a
 RAW264.7 mouse macrophages were seeded at a density of 0.2 × 105 cells mL-1, stimulated with LPS (0.1 µg mL-1 or 2µg mL-1) and treated with 0.050 and 
0.005% (w/v) 5 kDa UF permeates of sodium caseinate hydrolysates for 24 h. Cytokine production was measured using the enzyme-linked immunosorbent 
assay (ELISA) and values were expressed as a percentage relative to cells treated with LPS alone (Control): IL-6 concentration, control = 0.219 ng mL-1; IL-
1β concentration, control = 0.180 ng mL-1; TNF-α concentration, control = 0.721 ng mL-1. Data are the mean ± SE of 3 independent experiments; an asterisk 
denotes statistically significant difference (ANOVA followed by Dunnett’s test; P < 0.05) in cytokine production, compared with RAW264.7 mouse 
macrophages treated with LPS alone.   
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